mirt1 | 17011
Mirtazypine
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Blood sampling immediatly before administration of the next dose. Therapeutic range refers to trough level. | 4-Methylaminoantipyrine, a metabolite of metamizole, interferes with the determination of mirtazapine. Both substances are eluted together. Falsely increased mirtazapine concentrations are therefore possible with conmedication. |
||
| Stability |
Stability
2 days / 18-25°C; 2 weeks / 2-8°C; 2 weeks / -20°C
|
||
| Duration | 4 days | ||
| Frequency | 2 x per week | ||
| Method | Liquid chromatography / mass spectrometry (LCMS) |
Price/Rate
| Price |
Price
CHF 0.00
|
|---|---|
| Rate |
Rate
0.00 TP
|
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| 30 - 80 µg/L | f+m |
